Rapamycin increases Alzheimer’s-associated plaques in mice, study finds

<p>The research also reveals a novel way to decrease the plaques. This is a potential drug target. Contact: Will Sansom, (210) 567-2579, sansom@uthscsa.edu SAN ANTONIO (June 7, 2022) — Researchers from The University of Texas Health Science Center at San Antonio (UT Health San Antonio) have found that oral administration of rapamycin to an Alzheimer’s [&hellip;]</p>